Novel PARP1 Inhibitors for Treating Cancer.

Published in: ACS medicinal chemistry letters (2023)

Provided herein are novel PARP1 inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.

Keyphrases

papillary thyroid
dna damage
squamous cell
dna repair
lymph node metastasis
squamous cell carcinoma
childhood cancer